Works by Zhou, Zhiguang


Results: 381
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization.

    Published in:
    Cell Death & Disease, 2019, v. 10, n. 12, p. 1, doi. 10.1038/s41419-019-2130-z
    By:
    • Wang, Faxi;
    • Sun, Fei;
    • Luo, Jiahui;
    • Yue, Tiantian;
    • Chen, Longmin;
    • Zhou, Haifeng;
    • Zhang, Jing;
    • Yang, Chunliang;
    • Luo, Xi;
    • Zhou, Qing;
    • Zhu, He;
    • Li, Jinxiu;
    • Yang, Ping;
    • Xiong, Fei;
    • Yu, Qilin;
    • Zhang, Huilan;
    • Zhang, Wanguang;
    • Xu, Aimin;
    • Zhou, Zhiguang;
    • Lu, Qianjin
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    The missing heritability in type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 10, p. 1901, doi. 10.1111/dom.14777
    By:
    • Pang, Haipeng;
    • Lin, Jian;
    • Luo, Shuoming;
    • Huang, Gan;
    • Li, Xia;
    • Xie, Zhiguo;
    • Zhou, Zhiguang
    Publication type:
    Article
    35
    36
    37

    Frequency, clinical features, inflammatory cytokines and genetic background of latent autoimmune diabetes in youth in youth‐onset type 2 diabetes: Results from a nationwide, multicentre, clinic‐based, cross‐sectional study (LADA China).

    Published in:
    Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1282, doi. 10.1111/dom.14336
    By:
    • Xiang, Yufei;
    • Liu, Bingwen;
    • Yun, Chuan;
    • Zhou, Pengcheng;
    • Li, Xiaojue;
    • Luo, Shuoming;
    • Xie, Zhiguo;
    • Che, Zhihong;
    • Lin, Jian;
    • Yang, Lin;
    • Li, Xia;
    • Huang, Gan;
    • Xu, Aimin;
    • Zhou, Zhiguang
    Publication type:
    Article
    38
    39
    40
    41

    Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial.

    Published in:
    SCIENCE CHINA Life Sciences, 2017, v. 60, n. 3, p. 225, doi. 10.1007/s11427-016-0409-7
    By:
    • Xu, Wen;
    • Mu, Yiming;
    • Zhao, Jiajun;
    • Zhu, Dalong;
    • Ji, Qiuhe;
    • Zhou, Zhiguang;
    • Yao, Bin;
    • Mao, Anhua;
    • Engel, Samuel;
    • Zhao, Bin;
    • Bi, Yan;
    • Zeng, Longyi;
    • Ran, Xingwu;
    • Lu, Juming;
    • Ji, Linong;
    • Yang, Wenying;
    • Jia, Weiping;
    • Weng, Jianping
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50